2 completed. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow sucroferric oxyhydroxide: new trials by email Literature Review of sucroferric oxyhydroxide trials Research Report on sucroferric oxyhydroxide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Efficacy of Tenapanor as Adjunctive Therapy to Phosphate Binder Therapy Tenapanor, Placebo, Phosphate Binder Agents - Hyperphosphatemia | Phase 2 / Phase 3 | Completed | Ardelyx | 236 | 2019-02-28 | 2023-03-06 |
| The Effect of Phosphate Lowering Using Sucroferric Oxyhydroxide (PA21) on Calcification Propensity of Serum low-dose sucroferric oxyhydroxide, high-dose sucroferric oxyhydroxide - Endstage Renal Disease | Phase 2 | Completed | Prim. Priv. Doz. Dr. Daniel Cejka | 40 | 2017-06-09 | 2019-07-22 |
Ardelyx (1) · Prim. Priv. Doz. Dr. Daniel Cejka (1)
Austria (1) · United States (1)
Daniel Cejka, Dr. (1) · David P Rosenbaum, PhD (1)